跳至主要内容
临床试验/NCT07305766
NCT07305766已完成不适用

Construction and Preliminary Application of Evidence-Based Nursing Protocol for Oral Mucositis Related to Tumor Therapy

Peking Union Medical College1 个研究点 分布在 1 个国家目标入组 54 人开始时间: 2023年10月1日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
54
试验地点
1
主要终点
Incidence of oral mucositis

研究概览

简要总结

Describe the incidence and influencing factors of cancer therapy-related oral mucositis. Based on evidence-based practice, develop a standardized nursing protocol for cancer therapy-related oral mucositis that aligns with China's national context and demonstrates strong clinical feasibility, and establish a clinical management pathway for cancer therapy-related oral mucositis. Validate the implementability of the standardized nursing protocol, and evaluate its clinical effectiveness and cost-effectiveness.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with a confirmed cancer diagnosis who are aware of their condition.
  • Patients currently undergoing non-surgical treatments such as chemotherapy, radiotherapy, immunotherapy, or targeted therapy.
  • Patients who voluntarily agree to participate in this study and provide informed consent.

排除标准

  • Patients with autoimmune diseases;
  • Patients with primary or metastatic oral or lip cancer.;
  • Patients who are participating in other intervention studies.;
  • Swallowing problems existed in patients with Kubota drinking test > level 3;
  • Coma or inability to open mouth, difficulty cooperating with the researcher.

结局指标

主要结局

Incidence of oral mucositis

时间窗: One treatment cycle (21days)

WHO Oral Mucositis Assessment Scale

次要结局

  • Oral Condition Assessment(One treatment cycle (21days))
  • Salivary pH(One treatment cycle (21days))

研究者

发起方
Peking Union Medical College
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yutong XU

Master

Peking Union Medical College

研究点 (1)

Loading locations...

相似试验